You are here » Home » Companies » Company Overview » Aurobindo Pharma Ltd

Aurobindo Pharma Ltd.

BSE: 524804	Sector: Health care
NSE: AUROPHARMA	ISIN Code: INE406A01037

BSE 14:15 | 13 Apr

912.35

-3.80
(-0.41%)

OPEN

919.00

HIGH

924.95

LOW

887.10

NSE 14:09 | 13 Apr

909.45

-5.75
(-0.63%)

OPEN

917.10

HIGH

925.00

LOW

889.50

Add to Watchlist | Add to Portfolio

OPEN	919.00
PREVIOUS CLOSE	916.15
VOLUME	95729
52-Week high	1023.10
52-Week low	393.75
P/E	17.93
Mkt Cap.(Rs cr)	53,455
Buy Price	911.95
Buy Qty	24.00
Sell Price	912.35
Sell Qty	48.00

OPEN	919.00
CLOSE	916.15
VOLUME	95729
52-Week high	1023.10
52-Week low	393.75
P/E	17.93
Mkt Cap.(Rs cr)	53,455
Buy Price	911.95
Buy Qty	24.00
Sell Price	912.35
Sell Qty	48.00

Click here for interactive graph

Aurobindo Pharma Ltd. (AUROPHARMA) - Latest News & Headlines

Aurobindo Pharma steady as analysts watch numbers for near-term growth

1.14 am | 13 Feb 2021 | Business Standard

The company's investments across segments will take at least two years to play out, say analysts
Sensex ends 222 pts higher, Nifty tops 15,150; RIL gains 4%, PSB stocks dip

4.06 pm | 11 Feb 2021 | Business Standard

On the sectoral front, Nifty PSU Bank index declined over 1 per cent on the NSE, followed by losses in the Nifty Auto index (down 0.4 per cent), and t...
Why pharma stocks are underperforming despite Rs 2.23 trn Budget allocation

12.40 pm | 2 Feb 2021 | Business Standard

Much of the increase in this year's Budget allocation for health and well-being is attributed to expenditure set aside for Covid-19 vaccination
Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs

10.46 am | 25 Jan 2021 | Business Standard

Aurobindo Pharma (through Lyfius Pharma) has received government approval for setting up plants for production of Penicillin-G and 7-ACA, under the PL...
Here's a Bull Spread Strategy on Aurobindo Pharma by HDFC Securities

8.55 am | 28 Dec 2020 | Business Standard

The stock price has broken out from the downward slopping trendline
Share of family-owned firms in total market capitalisation rises to 64.5%

12.34 am | 28 Dec 2020 | Business Standard

The combined m-cap of all private sector companies rose by 24.4 per cent this year to Rs 142.4 trillion as of December 24, up from Rs 114.5 trillion a...
Aurobindo Pharma joins hands with Covaxx for coronavirus vaccine

1.17 am | 25 Dec 2020 | Press Trust of India

According to a release issued by the drug maker, Covaxx is currently conducting a Phase 1 clinical trial for the vaccine candidate
Weekly stock picks by Religare Broking: Buy Aurobindo Pharma, Marico

8.19 am | 25 Nov 2020 | Business Standard

The chart pattern and positioning of oscillators are pointing towards a sharp up move in Aurobindo Pharma in the near future
ITC, TCS: Trading strategies for defensive stocks in a volatile session

1.22 pm | 20 Nov 2020 | Business Standard

Major stocks are showing upside bias with support from moving averages and technical parameters
Stocks to watch: Aurobindo Pharma, Eicher Motors, IRCTC, Coal India, IGL

9.05 am | 12 Nov 2020 | Business Standard

Here's a list of stocks that may trade actively in today's session.
Divi's Lab, Aurobindo Pharma: Are pharma stocks losing their sheen? Read on

11.50 am | 11 Nov 2020 | Business Standard

Till Nifty Pharma holds above the 11,180 mark, the bullish bias will prevail, charts suggest.
Aurobindo Pharma to sell US-based Natrol for about Rs 4,048 crore

1.46 am | 27 Oct 2020 | Business Standard

Aurobindo's stock reacted positively to the news, going up in morning trade but later settled flat at Rs 784.65 on the BSE
Aurobindo Pharma declines 6% on USFDA warning letter for Dayton facility

10.55 am | 22 Oct 2020 | Business Standard

The company said it would engage with the regulator and would try to resolve the issue at the earliest
Stock recommendation by Prabhudas Lilladher: Buy Hindalco, Aurobindo Pharma

7.51 am | 19 Oct 2020 | Business Standard

The RSI indicator for Hindalco Industries has recently indicated a decent rise to imply strength